Homeostatic chemokine receptors and organ-specific metastasis

It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented. Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyse the studies to date and identify future challenges facing this field. Metastasis is the major factor that limits survival in most patients with cancer. Therefore, understanding the molecular mechanisms that control the metastatic behaviour of tumour cells is pivotal for treating cancer successfully. Substantial experimental and clinical evidence supports the conclusion that molecular mechanisms control organ-specific metastasis. One of the most important mechanisms operating in metastasis involves homeostatic chemokines and their receptors. Here, we review this field and propose a model of 'cellular highways' to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis.

[1]  K. Kabashima,et al.  CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. , 2007, The American journal of pathology.

[2]  Chang-liang Wang,et al.  The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. , 2011, The Journal of surgical research.

[3]  S. Xiong,et al.  Differential Expression of CXCR4 Is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells , 2005, Clinical Cancer Research.

[4]  Yu Wang,et al.  Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease , 2010, Journal of Pharmacology and Experimental Therapeutics.

[5]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[6]  B. Nürnberg,et al.  Tumor immune escape by the loss of homeostatic chemokine expression , 2007, Proceedings of the National Academy of Sciences.

[7]  S. McColl,et al.  Multiple functions of CXCL12 in a syngeneic model of breast cancer , 2010, Molecular Cancer.

[8]  R. Bachelder,et al.  Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. , 2002, Cancer research.

[9]  Sandro Sonnino,et al.  Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses , 2010, Nature Medicine.

[10]  Melody A. Swartz,et al.  Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21 , 2010, Science.

[11]  M. Imamura,et al.  Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[13]  G. Botti,et al.  Human Melanoma Metastases Express Functional CXCR4 , 2006, Clinical Cancer Research.

[14]  H. Kiyono,et al.  CCR7 Is Critically Important for Migration of Dendritic Cells in Intestinal Lamina Propria to Mesenteric Lymph Nodes1 , 2006, The Journal of Immunology.

[15]  Max S Wicha,et al.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Botti,et al.  Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome , 2010, Cancer biology & therapy.

[17]  N. Wake,et al.  Prognostic implications of the nuclear localization of Y‐box‐binding protein‐1 and CXCR4 expression in ovarian cancer: Their correlation with activated Akt, LRP/MVP and P‐glycoprotein expression , 2007, Cancer science.

[18]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[19]  Y. Harabuchi,et al.  Expression of CXCR4 and Its Down-Regulation by IFN-γ in Head and Neck Squamous Cell Carcinoma , 2005, Clinical Cancer Research.

[20]  D. Gilmour,et al.  The Chemokine SDF1a Coordinates Tissue Migration through the Spatially Restricted Activation of Cxcr7 and Cxcr4b , 2007, Current Biology.

[21]  M. Dorf,et al.  This information is current as Trigger Lymphoid Neogenesis Chemokine TCA 4 / SLC Is Sufficient to Cutting Edge : Ectopic Expression of the , 2000 .

[22]  E. Galun,et al.  Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  F. Balkwill,et al.  Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  H. Wiley,et al.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.

[25]  Y. Iwamoto,et al.  CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis , 2006, Modern Pathology.

[26]  B. Fingleton,et al.  Molecular targets in metastasis: lessons from genomic approaches. , 2007, Cancer genomics & proteomics.

[27]  R. M. Peters,et al.  Traumatic rupture of the bronchus; a clinical and experimental study. , 1958, Annals of surgery.

[28]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[29]  E. Raz,et al.  The role of CXCR7 in regulating primordial germ cell migration , 2008 .

[30]  G. Hortobagyi,et al.  Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. , 2004, Cancer cell.

[31]  M. Wendt,et al.  Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells , 2008, Oncogene.

[32]  W. Agace.  Generation of gut-homing T cells and their localization to the small intestinal mucosa. , 2010, Immunology letters.

[33]  J. Oord.  The CCR9–CCL25 axis mediates melanoma metastasis to the small intestine , 2008, Nature Clinical Practice Oncology.

[34]  J. Bahr,et al.  Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors , 2011, Journal of Ovarian Research.

[35]  Q. Chu,et al.  Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC) , 2008, Breast Cancer Research and Treatment.

[36]  D. Meyer,et al.  Guidance of Primordial Germ Cell Migration by the Chemokine SDF-1 , 2002, Cell.

[37]  D. Rosskopf,et al.  Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. , 2005, European urology.

[38]  C. Decaestecker,et al.  High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma , 2009, British Journal of Cancer.

[39]  Mónica Sala-Valdés,et al.  Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non‐Hodgkin lymphomas with widespread nodular dissemination , 2004, Journal of leukocyte biology.

[40]  Erez Raz,et al.  Chemokine signaling in embryonic cell migration: a fisheye view , 2009, Development.

[41]  Iannis Aifantis,et al.  CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia , 2009, Nature.

[42]  Psachal A. Calloway,et al.  Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. , 2010, Translational oncology.

[43]  M. Shigemori,et al.  CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target , 2011, Brain Tumor Pathology.

[44]  M. Okcu,et al.  CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. , 2004, Journal of pediatric surgery.

[45]  A. Link,et al.  Dynamic Modulation of CCR7 Expression and Function on Naive T Lymphocytes In Vivo1 , 2008, The Journal of Immunology.

[46]  B. Homey,et al.  Chemokines in tumor-associated angiogenesis , 2009, Biological chemistry.

[47]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[48]  D. Bates,et al.  CCR7 Mediates Directed Growth of Melanomas Towards Lymphatics , 2011, Microcirculation.

[49]  R. González-Sarmiento,et al.  Breast cancer, a stem cell disease. , 2008, Current stem cell research & therapy.

[50]  Günter Bernhardt,et al.  Cooperating Mechanisms of CXCR5 and CCR7 in Development and Organization of Secondary Lymphoid Organs , 2003, The Journal of experimental medicine.

[51]  R. Turner,et al.  Chemokine Receptor CXCR4 Expression in Patients With Melanoma and Colorectal Cancer Liver Metastases and the Association With Disease Outcome , 2006, Annals of surgery.

[52]  G. Botti,et al.  "CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression". , 2010, Frontiers in bioscience.

[53]  H. Sakurai,et al.  Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. , 2006, Cancer research.

[54]  K. Seeger,et al.  Chemokine IL-8 and Chemokine Receptor CXCR3 and CXCR4 Gene Expression in Childhood Acute Lymphoblastic Leukemia at First Relapse , 2006, Journal of pediatric hematology/oncology.

[55]  Y. Fujiwara,et al.  An Indispensable Role for the Chemokine Receptor CCR10 in IgA Antibody-Secreting Cell Accumulation1 , 2008, The Journal of Immunology.

[56]  U. Höpken,et al.  Role of Homeostatic Chemokine and Sphingosine‐1‐Phosphate Receptors in the Organization of Lymphoid Tissue , 2003, Annals of the New York Academy of Sciences.

[57]  X. Wang,et al.  Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.

[58]  K. Nakashiro,et al.  Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. , 2009, Oncology reports.

[59]  A. Peled,et al.  Potential of CXCR4 antagonists for the treatment of metastatic lung cancer , 2011, Expert review of anticancer therapy.

[60]  R. Scolyer,et al.  Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine , 2008, Clinical Cancer Research.

[61]  H. Soto,et al.  CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.

[62]  K. Tsuneyama,et al.  Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer , 2008, Cancer science.

[63]  T. Meshel,et al.  Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. , 2008, Cytokine.

[64]  H. Klocker,et al.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. , 2004, Journal of experimental therapeutics & oncology.

[65]  W. Hohenberger,et al.  Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7 , 2005, International journal of cancer.

[66]  Xin Lu,et al.  Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.

[67]  S. Fuqua,et al.  Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. , 2011, Cancer research.

[68]  S. Badve,et al.  ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer , 2010, Cancer biology & therapy.

[69]  P. Allavena,et al.  Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. , 2010, European journal of cancer.

[70]  F. Tanaka,et al.  Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. , 2002, Cancer research.

[71]  Fumitaka Kikkawa,et al.  Involvement of SDF‐1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma , 2008 .

[72]  R. Ransohoff,et al.  Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce? , 2007, Neurotherapeutics.

[73]  W. Xue,et al.  Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs. , 2010, Biochemical and biophysical research communications.

[74]  C. Snyderman,et al.  Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy , 2006, International journal of cancer.

[75]  J. Ying,et al.  The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis , 2012, Medical Oncology.

[76]  Baocun Sun,et al.  Effect of Chemokine Receptors CCR7 on Disseminated Behavior of Human T cell Lymphoma: clinical and experimental study , 2011, Journal of experimental & clinical cancer research : CR.

[77]  John M L Ebos,et al.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. , 2009, Cancer cell.

[78]  Michael K. Wendt,et al.  Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis , 2006, Oncogene.

[79]  Y. Tsutsumi,et al.  NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy , 2009, Cancer Immunology, Immunotherapy.

[80]  D. Hanahan,et al.  BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. , 2000, Immunity.

[81]  F. Rossi,et al.  Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25 , 2009, The Journal of experimental medicine.

[82]  J. Minna,et al.  High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. , 2006, Cancer research.

[83]  G. Tseng,et al.  Biomarker profile in breast carcinomas presenting with bone metastasis. , 2009, International journal of clinical and experimental pathology.

[84]  H. Nagai,et al.  Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells , 2009, Molecular Cancer.

[85]  N. Copeland,et al.  TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. , 1997, Immunity.

[86]  D. Schadendorf,et al.  Functional CCR9 expression is associated with small intestinal metastasis. , 2004, The Journal of investigative dermatology.

[87]  Z. Zong,et al.  NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. , 2011, Oncology reports.

[88]  Volker Brinkmann,et al.  Sphingosine 1-phosphate (S1P) , 2011, Neurology.

[89]  P. Dorrestein,et al.  Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis , 2010, PloS one.

[90]  A. Zlotnik,et al.  The chemokine and chemokine receptor superfamilies and their molecular evolution , 2006, Genome Biology.

[91]  R. Thompson,et al.  CXCR4 mediates the proliferation of glioblastoma progenitor cells. , 2009, Cancer letters.

[92]  I. Takanami.  Overexpression of CCR7 mRNA in nonsmall cell lung cancer: Correlation with lymph node metastasis , 2003, International journal of cancer.

[93]  R. Förster,et al.  Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. , 2005, Blood.

[94]  Nicolas Cubedo,et al.  Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1 , 2007, BMC Developmental Biology.

[95]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[96]  Donald L. Weaver,et al.  Effect of occult metastases on survival in node-negative breast cancer. , 2011, The New England journal of medicine.

[97]  Hua-chong Ma,et al.  CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. , 2011, World journal of gastroenterology.

[98]  F. Nestle,et al.  Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. , 2002, Cancer research.

[99]  Matthew A. Silva,et al.  Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma. , 2010, Clinical therapeutics.

[100]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[101]  C. Rubini,et al.  Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. , 2006, European journal of cancer.

[102]  C. Nüsslein-Volhard,et al.  A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor , 2003, Nature.

[103]  P. Loetscher,et al.  Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function , 2000, The Journal of experimental medicine.

[104]  M. Uhlén,et al.  CXCR4 and cancer , 2010, Pathology international.

[105]  R. Dahiya,et al.  CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility , 2007, Clinical Cancer Research.

[106]  G. Mills,et al.  The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis , 2006, Proceedings of the National Academy of Sciences.

[107]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[108]  Douglas B. Evans,et al.  High Levels of Expression of Human Stromal Cell–Derived Factor-1 Are Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[109]  U. V. von Andrian,et al.  CXCL12 Mediates CCR7-independent Homing of Central Memory Cells, But Not Naive T Cells, in Peripheral Lymph Nodes , 2004, The Journal of experimental medicine.

[110]  J. Saffitz,et al.  Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart , 2005 .

[111]  B. Groner,et al.  Stem Cells of the Breast and Cancer Therapy , 2010, Women's health.

[112]  Weiqi Wang,et al.  Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1 , 2000, The Journal of Immunology.

[113]  P. Allavena,et al.  Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4 , 2004, Cancer Research.

[114]  B. Wood,et al.  Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. , 2003, Blood.

[115]  M. Thelen,et al.  CXCR7, CXCR4 and CXCL12: An eccentric trio? , 2008, Journal of Neuroimmunology.

[116]  Philipp Busch,et al.  Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. , 2005, Journal of the National Cancer Institute.

[117]  E. Raz,et al.  Killing the messenger , 2008, Cell adhesion & migration.

[118]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[119]  Lin Zhang,et al.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells , 2011, Nature.

[120]  L. van Neste,et al.  Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis , 2010, Oncogene.

[121]  R. Tollenaar,et al.  Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients , 2008, Cancer Microenvironment.

[122]  Xiao-Hua Wu,et al.  Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. , 2006, Gynecologic oncology.

[123]  P. Petrow,et al.  CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. , 2007, Arthritis and rheumatism.

[124]  P. Martín-jiménez,et al.  Anti‐CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia , 2006, Journal of leukocyte biology.